Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Panbela Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −11 vs. Q1 2023
- Shares held
- 410.9K
- −1.53M (−78.8%) vs. Q1 2023
- Total value
- $945.1K
- +$87.4K (+10.2%) vs. Q1 2023
- New holders
- 2
- 0 more added
- Sold out
- 13
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 11 | $115.8K |
| Q3 2023 | 7 | $71.8K |
| Q2 2023 | 9 | $945.1K |
| Q1 2023 | 20 | $857.7K |
| Q4 2022 | 15 | $34.5K |
| Q3 2022 | 17 | $801.0K |
| Q2 2022 | 13 | $111.0K |
| Q1 2022 | 16 | $1.78M |
| Q4 2021 | 17 | $1.72M |
| Q3 2021 | 18 | $2.41M |
| Q2 2021 | 17 | $3.12M |
| Q1 2021 | 15 | $2.74M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 235,819 | $542.4K | 1.94% | −190,544−44.7% | Reduced |
| Walleye Capital LLC | 94,536 | $217.4K | 0.00% | +94,536 | New |
| Hudson Bay Capital Management LP | 76,000 | $174.8K | 0.00% | −279,000−78.6% | Reduced |
| Tower Research Capital LLC (TRC) | 3,713 | $8.54K | 0.00% | +3,713 | New |
| UBS Group AG | 823 | $1.89K | 0.00% | −31,948−97.5% | Reduced |
| Morgan Stanley | 26 | $60 | 0.00% | −786−96.8% | Reduced |
| Wells Fargo & Company | 4 | $9 | 0.00% | −40−90.9% | Reduced |
| Bank of America Corp | 2 | $5 | 0.00% | −69−97.2% | Reduced |
| Advisor Group Holdings, Inc. | 2 | $4 | 0.00% | −75−97.4% | Reduced |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −394,901−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −335,324−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −163,024−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −68,549−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −53,142−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −48,050−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Moneta Group Investment Advisors LLC | 0 | $0 | 0.00% | −11,999−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,185−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,043−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −12−100.0% | Sold out |